Key result
MIST-A tests whether minocycline reduces day-5 infarct volume after thrombectomy for acute ischemic stroke.
Why the study?
Does minocycline reduce infarct volume and improve functional outcomes in adult patients undergoing mechanical thrombectomy for anterior circulation acute ischaemic stroke?
RCT (n=180)
Open-label, blinded-endpoint
Randomized
Yes
Does minocycline reduce infarct volume and improve functional outcomes in adult patients undergoing mechanical thrombectomy for anterior circulation acute ischaemic stroke?
Answers are grounded in this paper and cite their sources.
This study protocol describes a randomized trial to evaluate the efficacy of minocycline in reducing infarct volume in patients with acute ischemic stroke undergoing mechanical thrombectomy.
INTRODUCTION: Despite the implementation of mechanical thrombectomy, acute ischaemic stroke with large vessel occlusion (AIS-LVO) remains a significant health concern, characterised by substantial morbidity and mortality. Our trial aims to evaluate the efficacy and safety of minocycline in reducing infarct volume and improving functional outcomes in patients undergoing mechanical thrombectomy for anterior circulation AIS-LVO. METHODS AND ANALYSIS: The MIST-A trial is a prospective, randomised, open-label, blinded-endpoint trial to be conducted across 12 medical centres. The study will enrol 180 adult patients who have experienced an anterior circulation AIS-LVO and have undergone mechanical thrombectomy. These patients will be randomly divided into two groups: one receiving minocycline in addition to standard care and the other receiving only standard care. The primary efficacy outcome is the change in infarct volume as measured by MRI, from baseline to day 5. The secondary efficacy outcomes include the incidence of intracerebral haemorrhage occurring within 24 hours and the clinical scores between the baseline and follow-up assessments. The primary outcome will be assessed using a mixed-effects model to determine the association between treatment and outcomes. ETHICS AND DISSEMINATION: The study is approved by the Ethics Committee of Xijing Hospital (XJLL-KY20222186) and is registered at ClinicalTrials.gov (NCT05487417). This trial is estimated to end in the first quarter of 2025 and study findings are expected to be published in scientific journals that undergo peer review and also to be showcased at scientific conferences. TRIAL REGISTRATION NUMBER: NCT05487417.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2024) conducted an RCT in Acute anterior circulation ischaemic stroke with large vessel occlusion (AIS-LVO) (n=180). Minocycline vs. Standard care was evaluated on Change in infarct volume as measured by MRI, from baseline to day 5. The MIST-A trial will randomize 180 adult patients with anterior circulation AIS-LVO undergoing mechanical thrombectomy to minocycline or standard care to assess changes in infarct volume at day 5.
Synapse has enriched 10 related papers. Consider them for comparative context: